← Back to Clinical Trials
Recruiting NCT07602894

NCT07602894 Analgesia for Perineal Surgeries in High-risk Pediatric Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07602894
Status Recruiting
Phase —
Sponsor Zagazig University
Condition Analgesia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-07-20
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 12 Months
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Systemic analgesiaSacral multifidus plane block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-07-20 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Perioperative pain management in pediatric patients, especially for anorectal and penile surgeries, presents significant challenges for anesthetists. Complications associated with systemic analgesia, such as respiratory issues, cardiovascular problems, and neurological effects, can be avoided by using regional anesthesia. This study aims to evaluate the effectiveness of Ultrasound-Guided Sacral Multifidus Plane Block as a method for perioperative analgesia in high-risk pediatric patients undergoing anorectal and penile surgeries, to reduce the risks associated with systemic analgesia.

Eligibility Criteria

Inclusion Criteria: * Parents or caregivers' acceptance. * High-risk pediatric patients (the American Society of Anesthesiologists physical status class III-IV) * Body mass index equal to 5%: 85% of the same age and sex. Exclusion Criteria: * Child with a contraindication to the regional block, such as infection at the site of injection, or coagulopathy. * Pre-existing neurological disorders.

Contact & Investigator

Central Contact

Abdalla Mohamed Goda Mohamed, MD

✉ drabdogoda@gmail.com

📞 1114166085

Principal Investigator

Abdelrazek yousef, MD

PRINCIPAL INVESTIGATOR

Department of Pediatric surgery, Zagazig University

Frequently Asked Questions

Who can join the NCT07602894 clinical trial?

This trial is open to participants of all sexes, aged 12 Months or older, up to 12 Years, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07602894 currently recruiting?

Yes, NCT07602894 is actively recruiting participants. Contact the research team at drabdogoda@gmail.com for enrollment information.

Where is the NCT07602894 trial being conducted?

This trial is being conducted at Zagazig, Egypt.

Who is sponsoring the NCT07602894 clinical trial?

NCT07602894 is sponsored by Zagazig University. The principal investigator is Abdelrazek yousef, MD at Department of Pediatric surgery, Zagazig University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology